Journals / Türk Oftalmoloji Dergisi / 2011 / Cilt: 41 - Sayı: 5

Evaluation of factors influencing the outcomes of selective laser trabeculoplasty in primary open-angle glaucoma

Primer açık açılı glokomda selektif lazer trabeküloplasti sonuçlarını etkileyen faktörlerin değerlendirilmesi

Pages
304–308
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Re sults: Overall, 1-year after SLT, the mean IOP reduction was 4.7±3.2 mmHg and the mean success rate was 59.3±6%.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To determine demographic and clinical factors that affect the outcomes of selective laser trabeculoplasty (SLT) in patients with primary open-angle glaucoma (POAG).
📊
Key Findings & Data:Materi al and Met hod: In this retrospective study, we analyzed the medical records of 54 eyes of 39 patients who underwent SLT treatment for POAG.
💡
Conclusion & Impact:Re sults: Overall, 1-year after SLT, the mean IOP reduction was 4.7±3.2 mmHg and the mean success rate was 59.3±6%.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: To determine demographic and clinical factors that affect the outcomes of selective laser trabeculoplasty (SLT) in patients with primary open-angle glaucoma (POAG). Materi al and Met hod: In this retrospective study, we analyzed the medical records of 54 eyes of 39 patients who underwent SLT treatment for POAG. Effects of demographic characteristics including age, sex, treated eyes, and family history of glaucoma on SLT success were investigated. Effects of clinical features including baseline intraocular pressure (IOP), baseline number of antiglaucomatous medications,baseline cup to disc ratio (c/d), trabecular meshwork (TM) pigmentation, central corneal thickness, and number of laser spots on SLT success were also evaluated. Success was defined as a ≥ 20% reduction in IOP without additional medications, laser, or glaucoma surgery. Re sults: Overall, 1-year after SLT, the mean IOP reduction was 4.7±3.2 mmHg and the mean success rate was 59.3±6%. Among the all investigated factors, only baseline IOP was a significant predictor for the efficacy of SLT in POAG (p

Özet

Amaç: Primer açık açılı glokomlu (PAAG) hastalarda Selektif Lazer Trabeküloplasti (SLT) sonuçlarına etki eden klinik ve demografik özellikleri saptamak. Gereç ve Yöntem: Bu retrospektif çalışmada, PAAG için SLT tedavisi uygulanan 39 hastanın 54 gözüne ait tıbbi kayıtları incelendi. Yaş, cinsiyet, tedavi edilen göz, ailede glokom hikâyesi gibi demografik özelliklerin SLT başarısına etkisi araştırıldı. Ayrıca, başlangıç GİB değeri,antiglokomatöz ilaç sayısı, çukurluk-disk oranı (c/d), trabeküler ağ (TA) pigmentasyonu, santral kornea kalınlığı ve uygulanan lazer spot sayısı gibi klinik özelliklerin SLT başarısına etkisi değerlendirildi. Ek medikal, lazer veya cerrahi tedavisi olmaksızın lazer öncesine göre %20 ve üzeri GİB azalması başarı olarak tanımlandı. Sonuçlar: Genel olarak, SLT sonrası 1. yılda ortalama GİB azalması 4,7±3,2 mmHg ve başarı oranı %59,3±6 idi. SLT uygulanan PAAG’da,incelenen tüm faktörler arasından sadece başlangıç GİB SLT etkinliğinde önemli bir belirleyici idi (p

🔖

Cite This Article

KARA, N., ALTINKAYNAK, H., YILMAZ, Ö. F., DEMİROK, A., ŞATANA, B., ALTAN, Ç., YÜKSEL, K. (2022). Evaluation of factors influencing the outcomes of selective laser trabeculoplasty in primary open-angle glaucoma. Türk Oftalmoloji Dergisi, Cilt: 41 - Sayı: 5, 304–308. https://ajindex.com/articles/638378

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Buys YM. Economics of selective laser trabeculoplasty as primary therapy for glaucoma. Can J Ophthalmol. 2006;41:419-20
  2. Lee R, Hutnik CM. Projected cost comparison of selective laser trabeculoplasty versus glaucoma medication in the Ontario Health Insurance Plan. Can J Ophthalmol. 2006;41:449-56
  3. Wise JB, Witter SL. Argon laser therapy for open-angle glaucoma: a pilot study. Arch Ophthalmol. 1979;97:319-22
  4. The Glaucoma Laser Trial (GLT) and glaucoma laser trial follow-up study: 7. Results. Glaucoma Laser Trial Research Group. Am J Ophthalmol. 1995;120:718-31
  5. Latina MA, Sibayan SA, Shin DH, Noecker RJ, Marcellino G. Q-switched 532-nmNd:YAG laser trabeculoplasty (selective laser trabeculoplasty): amulticenter, pilot, clinical study. Ophthalmology. 1998;105:2082-90
  6. Hoskins HD, Hetherington J, Minckler DS, Lieberman MF, Shaffer RN. Complications of laser trabeculoplasty. Ophthalmology. 1983;90:796-9
  7. Melamed S, Simon GB, Levkovitch-Verbin H. Selective laser trabeculoplasty as a primary treatment for open-angle glaucoma. Arch Ophthalmol. 2003;121:957-60
  8. Chen E, Golchin s, Blomdahl S. A comparison between 90 degrees and 180 degrees selective laser trabeculoplasty. J Glaucoma. 2004;13:62-5
  9. Kano K, Kuwayama Y, Mizoue S, Ito N. [Clinical results of selective laser trabeculoplasty] (abstract only; article in Japanese). Nippon Ganka Gakkai Zasshi 1999;103:612-16
  10. Cvenkel B. One-year follow-up of selective laser trabeculoplasty in openangle glaucoma. Ophthalmologica. 2004;218:20-5
  11. Kaulen P, Richter A, Wiemer C. Selective laser trabeculoplasty - results during the first two years. 97th Annual Meeting of the German Ophthalmology Society. Berlin. 1999:K14
  12. Kara N, Baz Ö, Altan Ç, et al. Fakik ve Psödofakik Gözlerde Selektif Lazer Trabeküloplastinin Etkinliği ve Güvenliği. Glo-Kat. 2011;6:49-52
  13. Damji KF, Shah KC, Rock WJ, Bains HS, Hodge WG. Selective laser trabeculoplasty v argon laser trabeculoplasty: a prospective randomized clinical trial. Br J Ophthalmol. 1999;83:718-22
  14. W Hodge WG, Damji KF, Rock W, Buhrmann R, Bovell AM, Pan Y. Baseline IOP predicts selective laser trabeculoplasty success at 1 year posttreatment:results from a randomised clinical trial. Br J Ophthalmol. 2005;89:1157-60
  15. Odberg T, Sandvik L. The medium and long-term efficacy of primary argon laser trabeculoplasty in avoiding topical medication in open angle glaucoma. Acta Ophthalmol Scand. 1999;77:176-81
  16. Kano K, Kuwayama Y, Mizoue S